中文名称 | 英文名称 | CAS号 | 化学式 | 分子量 |
---|---|---|---|---|
9,10-二羟基硬脂酸 | Dihydroxystearic Acid | 120-87-6 | C18H36O4 | 316.481 |
9,10-二羟基十八烷酸 | threo-9,10-dihydroxyoctadecanoic acid | 2391-05-1 | C18H36O4 | 316.481 |
9,10-二羟基十六烷酸 | 9,10-dihydroxy-hexadecanoic acid | 29242-09-9 | C16H32O4 | 288.428 |
—— | (Z)-(9S,10R)-9,10-dihydroxyoctadec-12-enoic acid | 125356-87-8 | C18H34O4 | 314.466 |
辛二酸 | Suberic acid | 505-48-6 | C8H14O4 | 174.197 |
反式-9,10-环氧十八烷酸 | 9,10-epoxystearic acid | 2443-39-2 | C18H34O3 | 298.466 |
外消旋反式-9,10-环氧硬脂酸 | trans-9,10-epoxystearic acid | 13980-07-9 | C18H34O3 | 298.466 |
—— | 10-hydroxy-9-oxo-octadecanoic acid | 13985-42-7 | C18H34O4 | 314.466 |
—— | 9-hydroxy-10-oxooctadecanoic acid | 13985-41-6 | C18H34O4 | 314.466 |
—— | (Z)-9,10-epoxyoctadecanoic acid methyl ester | 2566-91-8 | C19H36O3 | 312.493 |
中文名称 | 英文名称 | CAS号 | 化学式 | 分子量 |
---|---|---|---|---|
9,10-二羟基十八烷酸 | threo-9,10-dihydroxyoctadecanoic acid | 2391-05-1 | C18H36O4 | 316.481 |
—— | (+/-)-erythro-Octadecan-1,9,10-triol | —— | C18H38O3 | 302.498 |
壬二酸 | azelaic acid | 123-99-9 | C9H16O4 | 188.224 |
壬酸 | nonanoic acid | 112-05-0 | C9H18O2 | 158.241 |
辛二酸 | Suberic acid | 505-48-6 | C8H14O4 | 174.197 |
辛酸 | Octanoic acid | 124-07-2 | C8H16O2 | 144.214 |
9-氧代壬酸 | azelaic acid semialdehyde | 2553-17-5 | C9H16O3 | 172.224 |
—— | cis-9,10-epoxystearic acid | 24560-98-3 | C18H34O3 | 298.466 |
—— | 10-hydroxy-9-oxo-octadecanoic acid | 13985-42-7 | C18H34O4 | 314.466 |
—— | 9-hydroxy-10-oxooctadecanoic acid | 13985-41-6 | C18H34O4 | 314.466 |
To monitor sales of non-prescription medicines from pharmacies in New Zealand, and report specifically on the involvement and influence of pharmacy staff.
Purchasers of non-prescription medicines were interviewed in-store immediately following their purchase. A brief structured questionnaire was used to record current and previous medicine purchases, influences on first-time purchases and demographic descriptors. Non-intrusive observational data were collected where possible in the case of non-response.
Data were collected in 12 pharmacies in New Zealand during winter 1999. Pharmacies were selected to approximate the population distribution, and had a range of sizes and practice settings. Interviews took place over five consecutive days in each pharmacy.
The recorded purchases totalled 2,597 (69–397 per pharmacy), representing 71.2 per cent of observed medicine sales. Some two-thirds of all medicines had been purchased on a previous occasion. In two-thirds of sales, pharmacy assistants provided consultation with no pharmacist input. Two-thirds of purchases were for a pre-determined brand, and consultation occurred less frequently when these were self-selected from the shelf. Involvement by pharmacy staff was particularly noted when a change of brand occurred, when a desired brand was sought from staff, and when no particular brand was sought. For first-time purchases, the influence of pharmacy staff (62.2 per cent of all influences recorded) dominated that of family and friends (15.5 per cent).
Pharmacy staff play an active role in non-prescription medicine sales, despite most purchases apparently being straightforward in nature. Guidelines for appropriate product selection and advice are particularly important when training pharmacy assistants.
Tobacco smoking is one of the principal risk factors of peripheral arterial disease (PAD); choles terol level has a lesser impact. The effect of leisure-time physical activity (LTPA) has not been studied in depth. The aim of this study was to determine the relative effects of smoking, total cholesterol, and leisure-time physical activity on blood flow parameters in the lower extremi ties of healthy middle-aged men with no prior symptoms or diagnosis of PAD.
The authors examined 130 men, aged 40-65 years, free of known arterial disease and hypertension. The men had either a total cholesterol concentration of <5.7 or > 7.0 mmol/L, and were either smokers or nonsmokers. LTPA was addressed by a questionnaire. Ankle-brachial index (ABI) was calculated and Doppler examination of the femoral artery was performed before and after an exercise test.
Tobacco smoking related significantly to abnormal ABI and Doppler results (odds ratio [OR] 2.42) while the total cholesterol level did not. LTPA had a favorable effect (OR 0.51). Abnormal ABI response was greatest in smokers with high total cholesterol (p < 0.01).
Tobacco smoking is a significant risk factor for abnormal ABI response and blood flow abnormalities in healthy men. Regular physical activity has a measurable protective effect. An abnormal ABI suggests early atherosclerosis and indicates risk factor assessment and physician intervention.